Researchers have developed a new genetic test that can determine whether breast cancer patients can avoid chemotherapy. Putting the test to work, researchers found that most women with early-stage breast cancer may be able to skip the treatment, although the same does not necessarily apply to those who have larger tumors or those with cancer that has started to spread. Of the more than 250,000 women in the US expected to be diagnosed with breast cancer, the new findings could benefit more than 63,000 with non-invasive, or early stage breast cancer.
New genetic test may save thousands of women from going through chemotherapy
More of Today's Solutions
Nigerian school accepts plastic bottles as payment for tuition fees
A school in Nigeria is taking an innovative approach to tackle the problem of plastic waste while also promoting education. The Morit International School, ...
Read MoreMPs vote to decriminalize abortion in England and Wales in historic victory f...
BY THE OPTIMIST DAILY EDITORIAL TEAM British lawmakers have voted to decriminalize abortion, ending the threat of prosecution for women who terminate pregnancies outside ...
Read MoreHow Hope Hydration turns advertising dollars into free, clean drinking water
BY THE OPTIMIST DAILY EDITORIAL TEAM In a world where advertising saturates nearly every surface, from billboards and buses to our scrolling thumbs, one ...
Read MoreEurope approves twice-yearly HIV prevention shot amid rising cases
BY THE OPTIMIST DAILY EDITORIAL TEAM Imagine replacing a daily pill with just two injections a year. That is now a reality in Europe, ...
Read More
